A phase 3 multicenter, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of the Sufentanil NanoTab PCA System for the treatment of post-operative pain after open abdominal surgery

M. Royal; H. Minkowitz; F. Ringold; T. Gan; P. Palmer

doi:10.1016/j.jpain.2013.01.671

A phase 3 multicenter, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of the Sufentanil NanoTab PCA System for the treatment of post-operative pain after open abdominal surgery

Journal of Pain ◽

10.1016/j.jpain.2013.01.671 ◽

2013 ◽

Vol 14 (4) ◽

pp. S83

Author(s):

M. Royal ◽

H. Minkowitz ◽

F. Ringold ◽

T. Gan ◽

P. Palmer

Keyword(s):

Abdominal Surgery ◽

Controlled Trial ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Post Operative Pain ◽

Open Abdominal Surgery

Download Full-text

929g Efficacy and safety of prucalopride in men with chronic constipation: a phase 3, randomized, double-blind, placebo-controlled trial

Gastroenterology ◽

10.1016/s0016-5085(14)60571-0 ◽

2014 ◽

Vol 146 (5) ◽

pp. S-160 ◽

Cited By ~ 2

Author(s):

Yan Yiannakou ◽

Michel Bouchoucha ◽

Ingolf Schiefke ◽

Hubert Piessevaux ◽

Rafal Filip ◽

...

Keyword(s):

Chronic Constipation ◽

Controlled Trial ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Results of a global phase 3, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of sebelipase alfa as an enzyme replacement therapy in children and adults with lysosomal acid lipase deficiency

Molecular Genetics and Metabolism ◽

10.1016/j.ymgme.2014.12.042 ◽

2015 ◽

Vol 114 (2) ◽

pp. S27

Author(s):

Barbara Burton

Keyword(s):

Enzyme Replacement Therapy ◽

Replacement Therapy ◽

Controlled Trial ◽

Efficacy And Safety ◽

Acid Lipase ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Lysosomal Acid ◽

Enzyme Replacement

Download Full-text

PWE-252 Efficacy and safety of prucalopride in men with chronic constipation: a phase 3, randomised, double-blind, placebo-controlled trial

Gut ◽

10.1136/gutjnl-2015-309861.698 ◽

2015 ◽

Vol 64 (Suppl 1) ◽

pp. A323.2-A324

Author(s):

Y Yiannakou ◽

M Bouchoucha ◽

I Schiefke ◽

H Piessevaux ◽

R Filip ◽

...

Keyword(s):

Chronic Constipation ◽

Controlled Trial ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and Safety of AR101 in Peanut Allergy: Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2017.12.941 ◽

2018 ◽

Vol 141 (2) ◽

pp. AB400

Author(s):

Stacie M. Jones ◽

Kirsten Beyer ◽

A. Wesley Burks ◽

Thomas B. Casale ◽

Jonathan O'B. Hourihane ◽

...

Keyword(s):

Peanut Allergy ◽

Controlled Trial ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Rationale and Design of LAPLACE-2: A Phase 3, Randomized, Double-Blind, Placebo- and Ezetimibe-Controlled Trial Evaluating the Efficacy and Safety of Evolocumab in Subjects With Hypercholesterolemia on Background Statin Therapy

Clinical Cardiology ◽

10.1002/clc.22252 ◽

2014 ◽

Vol 37 (4) ◽

pp. 195-203 ◽

Cited By ~ 10

Author(s):

Jennifer G. Robinson ◽

William J. Rogers ◽

Bettina S. Nedergaard ◽

Jonathan Fialkow ◽

Joel M. Neutel ◽

...

Keyword(s):

Statin Therapy ◽

Controlled Trial ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of istradefylline in moderate to severe Parkinson’s disease: A phase 3, multinational, randomized, double-blind, placebo-controlled trial (i-step study)

Journal of the Neurological Sciences ◽

10.1016/j.jns.2017.08.999 ◽

2017 ◽

Vol 381 ◽

pp. 351-352 ◽

Cited By ~ 1

Author(s):

S. Isaacson ◽

K. Eggert ◽

R. Kumar ◽

F. Stocchi ◽

A. Mori ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Controlled Trial ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Step Study

Download Full-text

EFFICACY AND SAFETY OF APREMILAST IN PATIENTS WITH MILD TO MODERATE PLAQUE PSORIASIS: RESULTS OF A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2021.07.040 ◽

2021 ◽

Author(s):

Linda Stein Gold ◽

Kim Papp ◽

David Pariser ◽

Lawrence Green ◽

Neal Bhatia ◽

...

Keyword(s):

Plaque Psoriasis ◽

Controlled Trial ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

FRI0448 Secukinumab Provides Sustained Improvements in The Signs and Symptoms of Active Psoriatic Arthritis: 2-Year Efficacy and Safety Results from The Phase 3 Randomised, Double-Blind, Placebo-Controlled Trial, Future 1

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2016-eular.3565 ◽

2016 ◽

Vol 75 (Suppl 2) ◽

pp. 598.1-598 ◽

Cited By ~ 1

Author(s):

A. Kavanaugh ◽

P. Mease ◽

A. Reimold ◽

H. Tahir ◽

J. Rech ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Controlled Trial ◽

Signs And Symptoms ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and Safety of Linaclotide in Patients with Irritable Bowel Syndrome with Constipation: Results from a Phase 3, Randomized, Double-blind, Placebo-controlled Trial in China and Other Regions

10.26226/morressier.57c5383cd462b80296c9b7be ◽

2016 ◽

Author(s):

Yunsheng Yang

Keyword(s):

Irritable Bowel Syndrome ◽

Controlled Trial ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Irritable Bowel

Download Full-text

Mo1646 Efficacy and Safety of Linaclotide in Patients With IBS-C: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial in China and Other Regions

Gastroenterology ◽

10.1016/s0016-5085(16)32517-3 ◽

2016 ◽

Vol 150 (4) ◽

pp. S741 ◽

Cited By ~ 2

Author(s):

Yunsheng Yang ◽

Jing-Yuan Fang ◽

Xiaozhong Guo ◽

Ning Dai ◽

Xizhong Shen ◽

...

Keyword(s):

Controlled Trial ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text